On this page
Canagliflozin
Active ingredient 3 prescription 4 with labelling
Overview
Source: NDC DirectoryIngredient name
CANAGLIFLOZIN
Base moiety
CANAGLIFLOZIN
RxNorm CUI
UNII
786Z46389E
Medication products
12
Brand names
3
Dosage forms
3
FAERS reports
91,381 · not a risk measure
- Canagliflozin Powder
- canagliflozin Tablet, Film Coated
- Canagliflozin (Amorphous) Powder
- Canagliflozin (Hemihydrate) Powder
- canagliflozin and metformin hydrochloride Tablet, Film Coated
- canagliflozin and metformin hydrochloride Tablet, Film Coated, Extended Release
- Canagliflozin crystalline Powder
- Canagliflozin Hemihydrate Powder
- not applicable Powder
- INVOKAMET canagliflozin and metformin hydrochloride · Tablet, Film Coated
- INVOKAMET XR canagliflozin and metformin hydrochloride · Tablet, Film Coated, Extended Release
- INVOKANA canagliflozin · Tablet, Film Coated
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 6 | Canagliflozin, Canagliflozin (Amorphous), Canagliflozin (Hemihydrate), Canagliflozin crystalline … |
| TABLET, Film Coated | 4 | canagliflozin, canagliflozin and metformin hydrochloride, INVOKAMET, INVOKANA |
| TABLET, Film COATED, Extended Release | 2 | canagliflozin and metformin hydrochloride, INVOKAMET XR |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |